Furthermore, a few studies previously shown that TRPV1 was likely involved in tumor progression [16], and its activation reduced cell proliferation, migration and invasion in breast cancer [17], urothelial cancer [18] and papillary thyroid carcinoma [19]. The gene discussed is TRPV1; the disease is neoplasm.